Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

Brooklyn Decker Takes Her UNC Basketball Seriously

Southern Historical Collection will use $877,000 grant to archive southern history

UNC's College of Arts & Sciences Receives $18 Million Gift

Carolina’s Innovation Showcase features promising commercial, social ventures

UNC Summer School celebrates 140th anniversary


© 2005-2017 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.